AVPI1 (arginine vasopressin induced 1) is a vasopressin-responsive gene with putative roles in cellular signaling and epithelial ion transport regulation. The gene encodes a protein that may facilitate MAP kinase cascade activation and negatively regulate epithelial sodium channel (ENaC) function, thereby modulating sodium transport in collecting duct and airway epithelial cells 1. AVPI1 expression is stimulated through cAMP-dependent, PKA-mediated transcriptional mechanisms downstream of vasopressin signaling 1. Beyond its classical role in adult epithelial physiology, AVPI1 exhibits unexpected expression in early human development; it is uniquely overexpressed approximately 22-fold higher in 8-cell embryos compared to embryonic stem cells, suggesting novel developmental functions distinct from its vasopressin-responsive role 2. In disease contexts, AVPI1 methylation patterns correlate with melanoma invasiveness, with differentially methylated regions associated with transcriptional changes between invasive and noninvasive melanoma cell lines, implicating epigenetic dysregulation of AVPI1 in cancer progression 3. The clinical significance remains incompletely characterized, though the gene's involvement in both epithelial ion homeostasis and cancer-associated methylation changes suggests potential therapeutic relevance in both renal/respiratory pathology and oncology.